Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro

Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer

(2012) A. G. Renehan et al.   DIABETOLOGIA

Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence

(2012) J. A. Johnson et al.   DIABETOLOGIA

Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression

(2011) Jiyoung Park et al.   ENDOCRINE REVIEWS

Multiple signal pathways in obesity-associated cancer

(2011) J. Chen   Obesity Reviews

Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle

(2011) C. La Vecchia et al.   ONCOLOGIST

Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma

(2010) Mahboobeh Razmkhah et al.   CELLULAR IMMUNOLOGY

Postoperative Mortality in Cancer Patients With Preexisting Diabetes: Systematic review and meta-analysis

(2010) B. B. Barone et al.   DIABETES CARE

Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death

(2010) A. Teresa Alberobello et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Linking diabetes and cancer: a consensus on complexity

(2010) Andrew Renehan et al.   LANCET

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk

(2010) Peter E. Clayton et al.   Nature Reviews Endocrinology

CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation

(2009) Thomas T. Murooka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-β1 and TNF-α

(2009) Javier Guerrero et al.   BREAST CANCER RESEARCH AND TREATMENT

Impaired Preadipocyte Differentiation in Human Abdominal Obesity: Role of Wnt, Tumor Necrosis Factor- , and Inflammation

(2009) P. Isakson et al.   DIABETES

Obesity and Breast Cancer: The Estrogen Connection

(2009) Margot P. Cleary et al.   ENDOCRINOLOGY

Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway

(2009) Hideki Makinoshima et al.   FEBS LETTERS

The development and endocrine functions of adipose tissue

(2009) Sylvia P. Poulos et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives

(2009) A. Macciò et al.   Obesity Reviews

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth

(2008) N. Kloting et al.   DIABETES

RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case–cohort study, 1984–2002

(2008) Christian Herder et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Many cytokines are very useful therapeutic targets in disease

(2008) Marc Feldmann   JOURNAL OF CLINICAL INVESTIGATION

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

(2008) Adilson Guilherme et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The Emerging Role of the Insulin-Like Growth Factor Pathway as a Therapeutic Target in Cancer

(2008) P. D. Ryan et al.   ONCOLOGIST

Epigenetic Reprogramming of IGF1 and Leptin Genes by Serum Deprivation in Multipotential Mesenchymal Stromal Cells

(2008) Cecilia Sanchez et al.   STEM CELLS